Olon owner to acquire Infa

Published: May 23, 2016

The P&R Group, the owner of Italian API manufacturer Olon, has agreed to acquire its compatrior Infa. The transaction, which should be completed in early July at the latest, will create a player with sales of over €300 million/year and “a significant player in Europe as well as in the US”, it claimed. Based at Rodano, near Milan, P&R owns SIR and Fidia Farmaceutici as well as Olon.

​​​Managment to acquire Shasun Pharma Solutions

Published: May 23, 2016

The board of the Indian pharmaceutical company Strides Shasun has notified the National Stock Exchange of India of its intention to divest Shasun Pharma Solutions to its current management for an enterprise value of €31.8 million, with funding from the promoter group of Strides Shasun. The transaction is expected to be completed in Q3, the second quarter of its own fiscal year.

Evonik acquires Air Products business

Published: May 18, 2016

Evonik Industries is acquiring the Performance Materials division of Air Products & Chemicals in a $3.8 billion deal which had been the subject of market rumours for several months. Air Products still intends to spin off the rest of its Materials Technologies segment, the Electronic Materials division, to shareholders as a separate public company called Versum Materials.

AMRI to acquire Euticals

Published: May 18, 2016

AMRI has signed a definitive agreement to acquire the Italian API manufacturer Euticals in a cash, share and seller note transaction valued at about $385 million. The deal, said company president and CEO William Marth, “will provide us an established custom synthesis presence in Europe and will further build on our expertise in complex APIs”. It will also make AMRI one of the global giants in fine chemicals.

IUCLID 6 is available, ECHA says

Published: May 04, 2016

Chesar launch postponed

PCAS in deal with Abivax

Published: May 04, 2016

Deal should go through to commercial manufacture

Frutarom makes fifth acquisition of 2016

Published: May 03, 2016

Extrakt Chemie joins long list of buys

Published: April 18, 2016

Western suppliers of pharmaceutical fine chemical suppliers are doing well right now, but will it last? We report from DCAT Week ‘16



Copyright © 2016 Mack Brooks Speciality Publishing.